Bortezomib-combination based therapy in relapsed-refractory myeloma patients. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.381. Disponível em: https://journals.pagepress.org/hmr/article/view/381. Acesso em: 4 jul. 2025.